Subscribe to ExpertReview

The latest research, meeting updates and CME, in your inbox.

Hong Kong · Sponsored

HPV immunisation in UK lowers the incidence of cervical cancer and CIN3

7 Dec 2021Oncology

Connie TANG

Share

This content is sponsored. It is intended for healthcare professionals only.

Human papillomavirus (HPV) can cause cervical cancer, anogenital cancers and head and neck cancers if long-lasting infections are triggered by high-risk HPV strains, accounting for the great burden of HPV-related cancers worldwide with an estimated incidence in 570,000 women and 600,000 men each year.

HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Log inRegister

Related posts

Stylized illustration of a large blue immune cell with surface receptors and yellow nuclei, surrounded by smaller cells.Research · OncologyESCAT v2 adds graded certainty tiers and a resistance scale for molecular targetsAn international ESMO expert panel has revised the 2018 ESCAT framework, restructuring Tier I, Tier II and Tier X, formalising tumour-agnostic gating criteria and adding a four-level scale for resistance biomarkers.8 Nov 2026